talquetamab
janssen
['multiplemyeloma', 'talquetamab']
johnson &amp; johnson is looking to expand its #multiplemyeloma offerings with #talquetamab, a drug that could become the first one approved to go after novel target #gprc5d. explains from #ash22 #cancer 
Tracking what's next in medical innovation from hospitals, payers, medtech, pharma, digital & beyond. A @breakingmedia site.